Dr. Koyfman on IMRT and SBRT Reirradiation for Head and Neck Cancer

Shlomo Koyfman, MD
Published: Thursday, Mar 16, 2017



Shlomo Koyfman, MD, associate staff, radiation oncology, Cleveland Clinic, discusses intensity-modulated radiation therapy (IMRT) and stereotactic body radiotherapy (SBRT) reirradiation for patients with head and neck cancer.

There are 2 different ways to conduct reirradiation, explains Koyfman. There is IMRT-based reirradiation, which is usually for 6 or 7 weeks, and there is SBRT, which is high doses of only a few treatments.

When compared, it was determined that the safety of both were better than previously thought. However, this comparison seemed to suggest that the patients who were living longer seemed to be the group who received IMRT reirradiation.
 


Shlomo Koyfman, MD, associate staff, radiation oncology, Cleveland Clinic, discusses intensity-modulated radiation therapy (IMRT) and stereotactic body radiotherapy (SBRT) reirradiation for patients with head and neck cancer.

There are 2 different ways to conduct reirradiation, explains Koyfman. There is IMRT-based reirradiation, which is usually for 6 or 7 weeks, and there is SBRT, which is high doses of only a few treatments.

When compared, it was determined that the safety of both were better than previously thought. However, this comparison seemed to suggest that the patients who were living longer seemed to be the group who received IMRT reirradiation.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x